Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory malignancies Meeting Abstract
| Authors: | Mita, M. M.; Mita, A. C.; Chmielowski, B.; Hamilton, E. P.; Pant, S.; Waltzman, R. J.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; Kurth, I.; Andreu, C.; Busby, R.; Darst, D. M.; Tavazoie, S. S.; Tavazoie, M.; Postow, M. A. |
| Abstract Title: | Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory malignancies |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 160s |
| Language: | English |
| ACCESSION: | WOS:000442916001466 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.3095 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3095 -- Source: Wos |
